Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:23
Governor visits Red Cross shelter as region awaits long term...
-
1:38
Nate Snead starts professional baseball journey
-
2:15
Brown Deer family has medical supplies and basement severely...
-
1:19
Florida Panthers GM Bill Zito credits ’82 Brewers with getting...
-
0:52
Wisconsin leaders highlight importance of missing child alerts...
-
2:05
Potawatomi guests lose more than transportation in valet parking...
-
3:03
Milwaukee Bucks, Brewers celebrate Mike Strehlow’s anchor career
-
2:42
’It’s junk now, but it wasn’t at first’: Drivers lend...
-
4:15
Milwaukee Bucks’ 2025-26 regular season schedule released
-
0:54
Milwaukee County remains in recovery phase, launches new website...
-
1:19
CBS 58 Hometowns LIVE: George Webb Restaurant
-
3:11
George Webb waitress serving up free burgers in 1987, 2018, and...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.